AFX Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of AFX Antibodies for targeting AFX protein, a crucial member of the forkhead box O (FoxO) transcription factor family. Monoclonal AFX Antibodies enable multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AFX protein plays a significant role in regulating cellular processes such as apoptosis, cell cycle progression, and metabolism, maintaining cellular homeostasis and responding to stress signals. AFX dysregulation has been implicated in various diseases, including cancer and metabolic disorders, highlighting its importance in both basic and applied research. Understanding AFX function and regulation provides valuable insights into cellular signaling pathways and their impact on disease development. AFX research continues to reveal new mechanisms of cellular regulation and potential therapeutic targets. Investigating AFX expression patterns helps identify biomarkers for disease progression and treatment response. Research with monoclonal AFX Antibodies from Santa Cruz Biotechnology advances scientific understanding of cellular regulation and disease mechanisms, supporting breakthrough discoveries in the scientific community.